Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Mar 16, 2026
Total Value: $10.17B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| UTHR | UNITED THERAPEUTICS CORP | 2,606,060 | $1.27B | 12.5% | $209.04 | +122.8% | Common | 91307C102 |
| ASND | ASCENDIS PHARMA | 5,111,111 | $1.09B | 10.7% | $129.64 | — | Sponsored ADR | 04351P101 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,807,500 | $1.053B | 10.3% | $138.83 | +267.9% | Common | 558868105 |
| ARGX | ARGENX SE | 990,000 | $833M | 8.2% | $186.36 | — | Sponsored ADR | 04016X101 |
| KRYS | KRYSTAL BIOTECH INC | 2,888,888 | $712M | 7.0% | $96.25 | +118.7% | Common | 501147102 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 10,625,000 | $705M | 6.9% | $29.07 | +68.6% | Common | 04280A100 |
| KYMR | KYMERA THERAPEUTICS INC | 7,474,747 | $582M | 5.7% | $40.15 | +68.2% | Common | 501575104 |
| GPCR | STRUCTURE THERAPEUTICS INC | 6,555,555 | $456M | 4.5% | $36.87 | — | SPONSORED ADS | 86366E106 |
| RNAM | AVIDITY BIOSCIENCES INC | 5,455,000 | $393M | 3.9% | $23.88 | +170.5% | Common | 05370A108 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 14,555,555 | $364M | 3.6% | $20.97 | — | SPONSORED ADS | 152309100 |
| CELC | CELCUITY INC | 3,111,111 | $310M | 3.0% | $82.21 | 0.0% | Common | 15102K100 |
| APLS | APELLIS PHARMACEUTICALS INC | 12,222,222 | $307M | 3.0% | $47.01 | -50.1% | Common | 03753U106 |
| VERA | VERA THERAPEUTICS INC | 5,888,888 | $298M | 2.9% | $36.12 | -1.7% | Common | 92337R101 |
| XBI | SPDR SERIES TRUST - S&P BIOTECH | 2,100,000 | $256M | 2.5% | $121.93 | — | ETF | 78464A870 |
| XENE | XENON PHARMACEUTICALS INC | 5,424,444 | $243M | 2.4% | $19.12 | +119.7% | Common | 98420N105 |
| TERN | TERNS PHARMACEUTICALS INC | 4,350,000 | $176M | 1.7% | $23.11 | 0.0% | Common | 880881107 |
| RVMD | REVOLUTION MEDICINES INC | 2,170,000 | $173M | 1.7% | $65.57 | 0.0% | Common | 76155X100 |
| QURE | UNIQURE NV | 6,150,000 | $147M | 1.4% | $19.34 | +99.5% | Common | N90064101 |
| SLNO | SOLENO THERAPEUTICS INC | 2,900,000 | $134M | 1.3% | $48.20 | +13.8% | Common | 834203309 |
| OCUL | OCULAR THERAPEUTIX INC | 10,777,777 | $131M | 1.3% | $8.56 | +41.9% | Common | 67576A100 |
| TSHA | TAYSHA GENE THERAPIES INC | 21,700,000 | $119M | 1.2% | $2.05 | +137.0% | Common | 877619106 |
| — | MIND MEDICINE (MINDMED) INC | 5,000,000 | $66.95M | 0.7% | $13.39 | — | Common | 60255C885 |
| PTCT | PTC THERAPEUTICS INC | 685,000 | $52.03M | 0.5% | $72.67 | 0.0% | Common | 69366J200 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1,500,000 | $46.68M | 0.5% | $27.43 | 0.0% | Common | 92790C104 |
| ORKA | ORUKA THERAPEUTICS INC | 1,333,340 | $40.41M | 0.4% | $14.82 | +88.0% | Common | 687604108 |
| ALKS | ALKERMES PLC | 1,400,000 | $39.17M | 0.4% | $28.91 | +3.6% | Common | G01767105 |
| APGE | APOGEE THERAPEUTICS INC | 500,000 | $37.74M | 0.4% | $62.99 | 0.0% | Common | 03770N101 |
| SEPN | SEPTERNA INC | 1,337,500 | $37.29M | 0.4% | $20.93 | +14.1% | Common | 81734D104 |
| LXEO | LEXEO THERAPEUTICS INC | 3,300,000 | $32.77M | 0.3% | $9.13 | 0.0% | Common | 52886X107 |
| MNKD | MANNKIND CORP | 4,444,444 | $25.2M | 0.2% | $3.56 | +54.8% | Common | 56400P706 |
| GHRS | GH RESEARCH PLC | 1,800,000 | $22.86M | 0.2% | $13.62 | 0.0% | ORDINARY SHARES | G3855L106 |
| INCY | INCYTE CORP | 135,000 | $13.33M | 0.1% | $96.76 | 0.0% | Common | 45337C102 |
| WHWK | WHITEHAWK THERAPEUTICS INC | 2,849,402 | $6.896M | 0.1% | $24.27 | -90.5% | Common | 00032Q104 |
| ASND | ASCENDIS PHARMA | 50,000 | $625K | 0.0% | $129.64 | — | Call | 04351P101 |